Clinical Study

Individualized Treatment For Nasopharyngeal Cancer Based On The Patient’S Dna

Posted Date: Apr 19, 2018

  • Investigator: Jordan Kharofa
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This study is being done to see how people with your type of cancer respond to different types or levels of chemotherapy, based on a specific viral marker in their blood. This viral marker is called the Epstein Barr virus, (EBV). A more individualized approach to treating your type of cancer might be found using this blood marker.


To Be Eligible For This Study, Patients Must Have Nasopharyngeal Cancer (In The Head And Neck Region Of Your Body) That Has Not Spread To Other Parts Of Your Body


Nrg-Hn001, Nasopharyngeal Carcinoma, Cancer, Head & Neck

For More Information:

Uc Cancer Institute

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.